Hélène Chapy

Hélène Chapy is a Principal Scientist in Drug Metabolism and Pharmacokinetics (DMPK) at Ipsen since September 2022, following a role as Research and Study Director at Oncodesign and Senior Scientist in In Vitro ADME at UCB. Previously, Hélène served as a Postdoctoral Fellow at Rutgers University, focusing on pharmacokinetics and pharmacodynamics of monoclonal antibodies in obesity, and as a PhD candidate at Université Paris Descartes, studying cationic compound transporters at blood-brain and blood-retina barriers. Hélène's educational background includes a PhD in Cellular Biology and Pharmacokinetics and degrees in Pharmacy and Chemistry from Université Paris Cité. Hélène has also contributed to teaching and project management, along with leading professional workshops in pharmacokinetics and modeling.